Stocks and InvestingStocks and Investing
Thu, September 16, 2021
Wed, September 15, 2021
Tue, September 14, 2021
Mon, September 13, 2021
Fri, September 10, 2021
Thu, September 9, 2021

Paul Matteis Upgraded (BMRN) to Strong Buy and Increased Target to $96 on, Sep 9th, 2021


Published on 2024-10-27 17:52:10 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Stifel, Upgraded "BioMarin Pharmaceutical Inc." (BMRN) to Strong Buy and Increased Target from $86 to $96 on, Sep 9th, 2021.

Paul has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, all agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $88 on, Thursday, July 29th, 2021